Cochrane Abstracts
Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Immunosuppressive Drug Therapy for Preventing Rejection Following Lung Transplantation in Cystic Fibrosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436857/all/Immunosuppressive_drug_therapy_for_preventing_rejection_following_lung_transplantation_in_cystic_fibrosis.
Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436857/all/Immunosuppressive_drug_therapy_for_preventing_rejection_following_lung_transplantation_in_cystic_fibrosis. Accessed December 5, 2024.
Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436857/all/Immunosuppressive_drug_therapy_for_preventing_rejection_following_lung_transplantation_in_cystic_fibrosis
Immunosuppressive Drug Therapy for Preventing Rejection Following Lung Transplantation in Cystic Fibrosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436857/all/Immunosuppressive_drug_therapy_for_preventing_rejection_following_lung_transplantation_in_cystic_fibrosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis
ID - 436857
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436857/all/Immunosuppressive_drug_therapy_for_preventing_rejection_following_lung_transplantation_in_cystic_fibrosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
